SG11201508057VA - Artificial transcription factors engineered to overcome endosomal entrapment - Google Patents
Artificial transcription factors engineered to overcome endosomal entrapmentInfo
- Publication number
- SG11201508057VA SG11201508057VA SG11201508057VA SG11201508057VA SG11201508057VA SG 11201508057V A SG11201508057V A SG 11201508057VA SG 11201508057V A SG11201508057V A SG 11201508057VA SG 11201508057V A SG11201508057V A SG 11201508057VA SG 11201508057V A SG11201508057V A SG 11201508057VA
- Authority
- SG
- Singapore
- Prior art keywords
- transcription factors
- artificial transcription
- endosomal entrapment
- engineered
- overcome
- Prior art date
Links
- 102000040945 Transcription factor Human genes 0.000 title 1
- 108091023040 Transcription factor Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
- C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Medicinal Preparation (AREA)
- Marine Sciences & Fisheries (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13162197 | 2013-04-03 | ||
PCT/EP2014/056589 WO2014161880A1 (en) | 2013-04-03 | 2014-04-02 | Artificial transcription factors engineered to overcome endosomal entrapment |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201508057VA true SG11201508057VA (en) | 2015-10-29 |
Family
ID=48044672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201508057VA SG11201508057VA (en) | 2013-04-03 | 2014-04-02 | Artificial transcription factors engineered to overcome endosomal entrapment |
Country Status (17)
Country | Link |
---|---|
US (1) | US20160046682A1 (ko) |
EP (1) | EP2981547A1 (ko) |
JP (1) | JP2016515595A (ko) |
KR (1) | KR20160002880A (ko) |
CN (1) | CN105339386A (ko) |
AR (1) | AR095982A1 (ko) |
AU (1) | AU2014247130A1 (ko) |
BR (1) | BR112015025283A2 (ko) |
CA (1) | CA2908455A1 (ko) |
EA (1) | EA201591593A1 (ko) |
MA (1) | MA38541A1 (ko) |
MX (1) | MX2015014021A (ko) |
PH (1) | PH12015502421A1 (ko) |
SG (1) | SG11201508057VA (ko) |
TN (1) | TN2015000437A1 (ko) |
TW (1) | TW201514202A (ko) |
WO (1) | WO2014161880A1 (ko) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016050934A1 (en) * | 2014-10-02 | 2016-04-07 | Aliophtha Ag | Endosomal disentanglement of artificial transcription factors |
US11371023B2 (en) * | 2016-11-22 | 2022-06-28 | Wisconsin Alumni Research Foundation | Artificial transcription factors and uses thereof |
CN106987599B (zh) * | 2017-03-28 | 2021-06-11 | 重庆医科大学 | 一种抑制人bcr-abl融合基因表达或导致人bcr-abl基因功能丧失的锌指核酸酶及其应用 |
CN107632160B (zh) * | 2017-08-30 | 2019-04-30 | 福建师范大学 | Celsr3蛋白在制备肝癌术后预后评估试剂盒中的应用、肝癌预后评估试剂盒及方法 |
AU2018375192B2 (en) * | 2017-12-01 | 2023-11-09 | Encoded Therapeutics, Inc. | Engineered DNA binding proteins |
CN110108887B (zh) * | 2019-05-05 | 2022-01-28 | 深港产学研基地(北京大学香港科技大学深圳研修院) | Mff在心衰中的应用 |
CN114375198A (zh) * | 2019-05-16 | 2022-04-19 | 波士顿大学董事会 | 受调控的合成基因表达系统 |
CN112695052A (zh) * | 2020-12-25 | 2021-04-23 | 华南农业大学 | 一种重组人糖皮质激素受体GRα-His蛋白及其表达和纯化方法 |
CN113499335B (zh) * | 2021-07-13 | 2023-06-20 | 中国人民解放军军事科学院军事医学研究院 | 一种靶向自噬融合治疗神经退行性疾病的药物 |
WO2023028598A1 (en) * | 2021-08-26 | 2023-03-02 | Donald Danforth Plant Science Center | Engineering disease resistance by editing the epigenome |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005003315A2 (en) | 2003-07-01 | 2005-01-13 | Allele Biotechnology & Pharmaceuticals, Inc. | Compositions and methods for peptide-assisted transfection |
WO2008063113A1 (en) | 2006-11-20 | 2008-05-29 | Cepep Iii Ab | Cell -penetrating peptides and constructs containing them consisting 15-25 amino acids of tumor supressor protein p14arf or p19arf |
US20110318830A1 (en) * | 2008-11-12 | 2011-12-29 | The Regents Of The University Of California | Compositions and methods for re-programming and re-differentiating cells |
KR101095841B1 (ko) | 2009-02-19 | 2011-12-21 | 주식회사 나이벡 | 표적 선택적 세포/조직 투과기능 활성을 가지는 펩타이드 및 그 용도 |
-
2014
- 2014-04-01 TW TW103112114A patent/TW201514202A/zh unknown
- 2014-04-01 AR ARP140101460A patent/AR095982A1/es unknown
- 2014-04-02 KR KR1020157031592A patent/KR20160002880A/ko not_active Application Discontinuation
- 2014-04-02 MX MX2015014021A patent/MX2015014021A/es unknown
- 2014-04-02 US US14/781,701 patent/US20160046682A1/en not_active Abandoned
- 2014-04-02 JP JP2016505804A patent/JP2016515595A/ja active Pending
- 2014-04-02 BR BR112015025283A patent/BR112015025283A2/pt not_active Application Discontinuation
- 2014-04-02 WO PCT/EP2014/056589 patent/WO2014161880A1/en active Application Filing
- 2014-04-02 AU AU2014247130A patent/AU2014247130A1/en not_active Abandoned
- 2014-04-02 CN CN201480031910.4A patent/CN105339386A/zh active Pending
- 2014-04-02 CA CA2908455A patent/CA2908455A1/en not_active Abandoned
- 2014-04-02 SG SG11201508057VA patent/SG11201508057VA/en unknown
- 2014-04-02 EP EP14714289.7A patent/EP2981547A1/en not_active Withdrawn
- 2014-04-02 EA EA201591593A patent/EA201591593A1/ru unknown
-
2015
- 2015-09-28 TN TN2015000437A patent/TN2015000437A1/en unknown
- 2015-10-20 PH PH12015502421A patent/PH12015502421A1/en unknown
- 2015-10-21 MA MA38541A patent/MA38541A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
MA38541A1 (fr) | 2017-02-28 |
AR095982A1 (es) | 2015-11-25 |
JP2016515595A (ja) | 2016-05-30 |
EP2981547A1 (en) | 2016-02-10 |
TW201514202A (zh) | 2015-04-16 |
WO2014161880A1 (en) | 2014-10-09 |
TN2015000437A1 (en) | 2017-01-03 |
US20160046682A1 (en) | 2016-02-18 |
EA201591593A1 (ru) | 2016-04-29 |
BR112015025283A2 (pt) | 2017-10-10 |
CN105339386A (zh) | 2016-02-17 |
AU2014247130A1 (en) | 2015-10-22 |
CA2908455A1 (en) | 2014-10-09 |
PH12015502421A1 (en) | 2016-02-22 |
MX2015014021A (es) | 2016-06-24 |
KR20160002880A (ko) | 2016-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276210B1 (en) | Mers-cov vaccine | |
IL279395A (en) | A vaccine | |
IL246002A0 (en) | New methods | |
HK1207967A1 (en) | Vaccine | |
EP2921506A4 (en) | MODIFIED POLYMER | |
HK1216155A1 (zh) | 水母來源的聚合物 | |
SG11201508057VA (en) | Artificial transcription factors engineered to overcome endosomal entrapment | |
ZA201508642B (en) | Malaria vaccine | |
EP2876161A4 (en) | VACCINE | |
GB201318084D0 (en) | Malaria vaccination | |
GB201223386D0 (en) | Vaccine | |
PL2970845T3 (pl) | Bioreaktor | |
GB201320756D0 (en) | Polymer process | |
HK1217206A1 (zh) | 疫苗 | |
GB201308738D0 (en) | Novel polymer conjugates | |
GB201309805D0 (en) | New polymer | |
GB201202090D0 (en) | Vaccine | |
DK2846829T3 (en) | Vaccine combinations | |
GB201317842D0 (en) | Improved polymer preparation | |
GB201309919D0 (en) | TC-Met-N-BG polymer edditive | |
GB201307707D0 (en) | Improved polymer preparation | |
GB201320646D0 (en) | Vaccine | |
GB201319487D0 (en) | Concept 7-9 | |
GB201315556D0 (en) | Vaccine | |
GB201217321D0 (en) | Vaccine |